Clinical Roundup Tumor-infiltrating clonal hematopoiesis findings validated by AI analysis July 25, 2025Vol.51 No.29
Clinical Roundup Van Andel scientists develop improved single-cell DNA methylation technique July 25, 2025Vol.51 No.29
Clinical Roundup Researchers develop nicotinamide N-methyl transferase inhibitor to block ovarian cancer tumor growth July 25, 2025Vol.51 No.29
Clinical Roundup Study reveals immune-based therapy that may be effective in hard-to-treat lung cancers July 25, 2025Vol.51 No.29
Clinical Roundup Secretogranin 2 binds LILRB4 resulting in immunosuppression, UT Southwestern study suggests July 25, 2025Vol.51 No.29
Drugs & Targets FDA extends review period for Blenrep combinations after unfavorable ODAC vote, EU approval July 25, 2025Vol.51 No.29By Jacquelyn Cobb
Drugs & Targets FDA issues CRL for RP1+ nivolumab BLA for treatment of advanced melanoma July 25, 2025Vol.51 No.29
Drugs & Targets FDA grants Breakthrough Therapy designation to elironrasib for lung cancer July 25, 2025Vol.51 No.29
Drugs & Targets EMA grants Orphan Drug designation for ICT01 as treatment for AML July 25, 2025Vol.51 No.29
